Immunosuppressants.
Conclusion of a non-exclusive discount contract in accordance with Section 130a Para. 8 sgb v on medicinal products with the active ingredient infliximab. at Germany
Classified in :
#Medicinal Product
#Immunosuppressant
Partner Opportunity
Key Values
| Worth | : | Refer Document |
| EMD | : | Refer Document |
| Doc Fees | : | Refer Document |
Key Date
| Due on | : | 27-May-2023 |
| Days to go | : | -892 Days |
| Opening on | : | Refer Document |
| Published on | : | 31-May-2021 |
Key Location
| Location | : | Germany |
| Address | : |
|
